Solid pharmaceutical formulation with delayed release

Details for Australian Patent Application No. 2009243759 (hide)

Owner Bayer Animal Health GmbH

Inventors Schmidt, Axel; Bach, Thomas; Rehagen, Martina; Traubel, Michael; Altreuther, Gertraut; Kanikanti, VenkataRangarao

Agent Davies Collison Cave

Pub. Number AU-A-2009243759

PCT Pub. Number WO2009/135593

Priority 10 2008 022 520.7 07.05.08 DE

Filing date 23 April 2009

Wipo publication date 12 November 2009

International Classifications

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/4152 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/662 (2006.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61K 31/7048 (2006.01)

A61K 38/15 (2006.01) Medicinal preparations containing peptides - Depsipeptides

Event Publications

25 November 2010 PCT application entered the National Phase

  PCT publication WO2009/135593 Priority application(s): WO2009/135593

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009243775-Synergistic active ingredient combinations

2009243756-Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals